Bavarian Nordic ASCHIX:BAVAC 84 Quick Ratio is 3.58 as of Mar. 2026, which is 61% above its 10-year median of 2.22. GuruFocus rates CHIX:BAVAC with a GF Score™ of 84/100 and a GF Value™ of kr162.46 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 1,416 Biotechnology companies, Bavarian Nordic AS ranks worse than 50.28% on this metric.
Bavarian Nordic AS has a quick ratio of 3.58. It generally indicates good short-term financial strength.
The historical rank and industry rank for Bavarian Nordic AS's Quick Ratio or its related term are showing as below:
CHIX:BAVAc'
s Quick Ratio Range Over the Past 10 Years
Min: 0.27 Med: 2.22 Max: 10.69
Current: 3.58
During the past 13 years, Bavarian Nordic AS's highest Quick Ratio was 10.69. The lowest was 0.27. And the median was 2.22.
CHIX:BAVAc's Quick Ratio is ranked worse than 50.28% of 1416
companies
in the Biotechnology industry
Industry Median: 3.6
vs CHIX:BAVAc: 3.58
Bavarian Nordic AS (CHIX:BAVAc) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Bavarian Nordic AS Quick Ratio Related Terms
Bavarian Nordic AS Quick Ratio Historical Data
* Premium members only.
The historical data trend for Bavarian Nordic AS's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BAVAC vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Bavarian Nordic AS's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bavarian Nordic AS Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Bavarian Nordic AS's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Bavarian Nordic AS's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS (CHIX:BAVAC) has a Quick Ratio of 3.58 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bavarian Nordic AS and its competitors. This is 61% above median its historical median of 2.22. Over the past decade, Bavarian Nordic AS's Quick Ratio has ranged from 0.27 to 10.69. According to the industry distribution chart, Bavarian Nordic AS ranks #712 out of 1416 companies in the Biotechnology industry, placing it in the top 50.3%.
Is Bavarian Nordic AS's Quick Ratio too high?
Bavarian Nordic AS's current Quick Ratio of 3.58 is 61% above median its 10-year median of 2.22. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 10.69. The Biotechnology industry median Quick Ratio is 3.60. Bavarian Nordic AS's value of 3.58 is 0.6% below this industry median. Based on the distribution chart, Bavarian Nordic AS ranks #712 out of 1416 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Bavarian Nordic AS has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #712 out of 1416 companies for Quick Ratio. This places Bavarian Nordic AS in the lower half of its industry. The industry median Quick Ratio is 3.60. Bavarian Nordic AS's value of 3.58 is 0.6% below this benchmark. Historically, Bavarian Nordic AS's own Quick Ratio has ranged from 0.27 to 10.69 over the past decade. While the company's 10-year median is 2.22 vs. the industry median of 3.60, Bavarian Nordic AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bavarian Nordic AS's current Quick Ratio of 3.58 is 0.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bavarian Nordic AS and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bavarian Nordic AS's current Quick Ratio is 3.58, which is 61% above median its own 10-year median of 2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (CHIX:BAVAC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr162.46, compared to a current price of kr188.30 — trading 15.9% above its estimated fair value. The current Quick Ratio is 3.58, which is 61% above median its 10-year median of 2.22 and 0.6% below the Biotechnology industry median of 3.60. Bavarian Nordic AS's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Bavarian Nordic AS (CHIX:BAVAC), the current Quick Ratio is 3.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?
Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued.
The current stock price of kr188.30 is trading 15.9% above its estimated GF Value™ of kr162.46.
GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.
Key valuation signals for CHIX:BAVAC:
Quick Ratio: 3.58 (61% above median its 10-year median of 2.22)
GF Value™: kr162.46 vs. price of kr188.30 (15.9% above fair value)
Industry Position: 0.6% below the Biotechnology median (#712 of 1416)
No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score
Get the complete analysis for CHIX:BAVAC
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BAVAC has been successfully added to your 
